Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
DeGrado continued: “I look forward to investigating Brilacidin further. Small molecule therapeutics with novel antiviral mechanisms of action will always be urgently needed. Given Brilacidin exerts antiviral activity prior to infection of cells, developing Brilacidin for potential prophylactic use by targeting the nasal passageway and lungs may be a particularly appealing clinical pathway.”
So Leo! Find a partner for nasal mist and inhaler. Pandemic over!
Good point. Hopefully we get more details
It will be interesting. Of the 40 cohorts how many received with remdesevir as SOC and what were those results
Good luck!!!
Topline results did not meet primary. The primary was a tough one, so we shall see more results by month end. There will be better info on how they proceed with Covid from that.
Otherwise. 11 million in the bank and ready to move on with OM phase 3 early next year.
It will be interesting to see patient population with remdesevir SOC and moderate.
Well said. Also. Only 3/4 of patients received 5 days.
Agree. It’s a falling knife knee jerk. I bet the additional data released will even spark a rise.
We will get more data by end of month.
Scared money do t make money
How do you know he hasn’t tapped them over past 2 weeks?
I’m hopeful that Leo releases data Friday after hours or Friday mid day. Let the world stir up chatter on all the platforms for a major rush on Monday.
Right. Huge bids and buybacks
There is no volume today. Very low.
This was an interesting post you had. Brilacidin is being contracted for anti fungal with FoxChase
https://abcnews.go.com/Health/fungal-disease-rise-west-possibly-tied-changing-climate/story?id=80582150
Top line data
What does this mean and where did u see this
The Phase 2 COVID-19 clinical trial data as of the date of this Form 10-Q remains blinded to the Company. The Company’s biostatistics vendor is currently engaged in analyzing and computing study data and they are expected to deliver Topline results to the Company during the second week of November, 2021.
I’d suspect that Leo will be getting the topline this week. He projected a week timeframe from data lock to topline in a previous correspondence. So data lock was last Wed.
I’d then hope he would have communication with Alfa and a few other top partner prospects to deliver the data prior to releasing to us the public.
Due to the fact we are a mature multi drug/indication company….he has to please our prospective suitors on all levels.
Let’s all hope for the best
Welcome Gail
There she goes. Itching to be green
.50 with a pullback to .35 leads to a slingshot to .86
At this point they have had B for almost 2 years. They should know the possibilities better than anyone.
Yes. Let’s hope for AS to maybe ante up and add b for Covid to the partner agreement.
We need a pipeline update for all the new folks!
http://www.ipharminc.com/stages-of-development
FYI - Covid is a drop in the bucket
Brilacidin has been tested in many humans for many years. That is a bonus here.
If a sick human goes to the hospital on early onset having the choking phlegm and Covid….Brilacidin for 5 days to save lives will be a big hit
Wtf are people even taking about? Can you repost the hypothesis and the facts where these drugs are used?
Not really. Up from low .20’s to .50 and consolidate with over 11 million volume? On a day that Pfizer says they have a pill for early Covid. Not bad at all in reality.
Again zanny. If results are good…. This opens up potential new indications. Value
Right. We get a critical phase 2 PR next week. The world is large. Covid rages on. Lots of money to be made with antiviral. IV or pill. I’m just hopeful that Bs MOAs are superior to others.
Winding tight now. Afternoon rise is on the horizon.
It was clear by the types of posts prior to open what was going to happen today. Go read all of them. You can CLEARLY see
Yes. Ignore. Next week we find out how valuable B will be in AntiViral market.
We still have OM, UP, etc………billion dollar indications. Alfa will run phase 3 in 2022 for UPS and ipix can have access to 25million dollars upon milestones.
Next week we get topline results for Covid
Youve always been pretty good at charts
I think we are on way UP!!! Let it rip
Okay well I’m in. Grabbed .333 and .327
Added 38000 more.
What was gap?
I’m going to join you. I’ll bite at .33-.34
Remember. The key to this trial for B…..is to prove it has ANTIVIRAL properties. We all know Covid will evolve and there will be more and more variants….so the MOA will be key for Covid but overall this opens up the door to other viruses and indications.
Can Covid EU possibly give IPIX millions in Revs in the very near future? Absolutely and that is a game changer for investors….but the long term ——we want to see antiviral properties confirmed.
The other indications already proven are billion dollar indications and much more lucrative than Covid. The higher the pps…the more and less dilutive funding.
Big week ahead next week. IMO.
Over 2 million first 45 min.